| Popis: |
This chapter reviewed 2019 publications that identify side effects of drugs that affect blood coagulation, fibrinolysis and hemostasis. Publications on warfarin, apixaban, dabigatran, rivaroxaban, edoxaban, betrixaban, bivalirudin, argatroban, unfractionated heparin, low molecular weight heparin, fondaparinux, aminocaproic acid, tranexamic acid, idarucizumab, andexanet alfa, and tissue plasminogen activators have been reviewed. In addition to the well-known risks of these medications such as bleeding or thrombotic events, rare adverse events reports were recognized. |
